- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07586605
Lying Positions in Intramuscular Injection (Lying)
The Effect of Three Different Lying Positions on Pain, Comfort, and Satisfaction Levels in Intramuscular Injection: A Randomized Controlled Trial
The aim of this study is to examine the effects of intramuscular (IM) injections administered in three different lying positions (supine, prone, and lateral) into the ventrogluteal site on patient pain, comfort, and procedural satisfaction. The study will be conducted as a randomized controlled experimental trial with three groups. In Experimental Group 1, patients will be placed in the supine position; in Experimental Group 2, the lateral position; and in Experimental Group 3, the prone position prior to the injection procedure, followed by an IM injection into the ventrogluteal site. Subsequent to the procedure, patients' pain, comfort, and procedural satisfaction levels will be assessed.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Handan Eren, PhD
- Phone Number: +905438712771
- Email: erennhandan@gmail.com
Study Locations
-
-
-
Yalova, Turkey (Türkiye), 77300
- Recruiting
- Yalova University
-
Contact:
- Handan Eren, PhD
- Phone Number: 05438712771
- Email: erennhandan@gmail.com
-
Sub-Investigator:
- Nurcan Uysal, PhD
-
Sub-Investigator:
- Seyda Can, PhD
-
Sub-Investigator:
- Ebru Naime Arıkan, MSc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Being 18 years of age or older,
- Having received an IM injection at least one week prior to the study,
- Absence of scars, ecchymosis, or hematomas at the injection site,
- Having a BMI between 18.5 and 24.9 kg/m²,
- Absence of lower extremity paralysis,
- Not receiving any oral or parenteral analgesic treatment prior to the injection.
Exclusion Criteria:
- Failure of the patient to respond to the questions in the post-procedure data collection form.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: experimental group 1
Supine position before intramuscular injection |
Lying position before intramuscular injection |
|
Experimental: experimental group 2
Lateral position before intramuscular injection |
Lying position before intramuscular injection |
|
Experimental: experimental group 3
Prone position before intramuscular injection |
Lying position before intramuscular injection |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analog Scale (VAS) Score for Pain
Time Frame: during the procedure
|
patient's pain level (0-10) |
during the procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Procedural Satisfaction Score
Time Frame: during the procedure
|
The Visual Analog Scale (VAS) (0-10) will be employed to measure the degree of patient satisfaction. |
during the procedure
|
|
Patient Comfort Level
Time Frame: During the procedure
|
The Visual Analog Scale (VAS) (0-10) will be employed to measure the degree of patient comfort level |
During the procedure
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2026/208
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.